Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients (ASCIT)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2011 by Universitaire Ziekenhuizen Leuven.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Kathleen Claes, Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier:
NCT00547040
First received: October 18, 2007
Last updated: October 5, 2011
Last verified: October 2011
  Purpose

The purpose of this study is to determine the:

  • Natural history of calcification posttransplantation
  • Natural history of BMC following renal transplantation
  • Reverse correlation between calcification score and aortic calcifications following renal transplantation
  • Correlation of IMT, BMC, PWV and biochemical variables
  • Correlation of IMT, BMC, PWV, biochemical variables and outcome
  • Predictors of CV disease after transplantation
  • Predictors of IMT progression, BMC loss and PWV progression after renal transplantation

Condition Intervention
Renal Transplant
Atherosclerosis
Arterial Stiffness
Other: no intervention

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients

Resource links provided by NLM:


Further study details as provided by Universitaire Ziekenhuizen Leuven:

Primary Outcome Measures:
  • cardiovascular outcome [ Time Frame: 5 years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

serum, plasma, urine


Estimated Enrollment: 100
Study Start Date: October 2006
Estimated Study Completion Date: October 2013
Groups/Cohorts Assigned Interventions
A
incident renal transplant patients
Other: no intervention
no intervention

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

incident renal transplant recipients

Criteria

Inclusion Criteria:

  • Incident renal transplant patients or combined renal/pancreas transplant patients
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00547040

Contacts
Contact: kathleen Claes, MD 0032/16344580 kathleen.claes@uz.kuleuven.ac.be

Locations
Belgium
UZ Gasthuisberg Recruiting
Leuven, Belgium, 3000
Sponsors and Collaborators
Universitaire Ziekenhuizen Leuven
Investigators
Principal Investigator: kathleen Claes, MD UZ Leuven
Principal Investigator: kathleen claes, md UZ Leuven
  More Information

No publications provided

Responsible Party: Kathleen Claes, md, Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier: NCT00547040     History of Changes
Other Study ID Numbers: ML3775
Study First Received: October 18, 2007
Last Updated: October 5, 2011
Health Authority: Belgium: Institutional Review Board

Keywords provided by Universitaire Ziekenhuizen Leuven:
calcification
bone lesions

Additional relevant MeSH terms:
Atherosclerosis
Calcinosis
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases
Calcium Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on April 17, 2014